Biden Seeks Coverage for GLP-1 RA Medications by Medicare, Medicaid

TUESDAY, Nov. 26, 2024-- The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) obesity medications like semaglutide (Wegovy) and tirzepatide (Zepbound), challenging a...